
|Articles|October 14, 2009
Emerging Leaderhip Pharma Awards- Frank Karbe
Advertisement
Frank Karbe,
Chief Financial Officer,
Exelixis
Download Adobe Flash Player
Frank Karbe, executive vice president and chief financial officer of Exelixis, reflects on some of the financial, regulatory, and intellectual property challenges facing the biopharma industry and shares his thoughts on what emerging leaders will need to do to address them.Listen to the Podcast for more coverage.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Evolving Relationship Between FDA and Biotech
4
What Kinds of Disruption are GLP-1s Expected to Face
5




